CD8A and melanoma: In melanoma‐bearing mice, blockade of MHC‐II—particularly on dendritic cells—promotes infiltration and activation of CD8+ T cells via cDC2‐mediated cross‐priming, and synergizes with immune checkpoint inhibitors to improve therapeutic efficacy.137